Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.
Pharmaceutics. 2013 Jul 1;5(3):371-84. doi: 10.3390/pharmaceutics5030371.
The use of a prodrug, a conjugate of an active drug with a lipophilic substituent, is a good way of increasing the cutaneous absorption of a drug. However, the activity of dermal hydrolases has rarely been investigated in humans, or experimental animals. In the present study, we focused on the identification of rat dermal esterases and the hydrolysis of a prodrug during permeation across rat skin. We found that carboxylesterase (CES), especially the rat CES1 isozyme, Hydrolase A, is expressed in rat skin and that the hydrolysis of p-nitrophenyl acyl derivatives and caproyl-propranolol (PL) was 20-fold lower in the 9000g supernatant fraction of skin homogenate than in liver microsomes. A permeation study of caproyl-PL was performed in rat full-thickness and stripped skin using a flow-through diffusion cell. Caproyl-PL was easily partitioned into the stratum corneum and retained, not only in the stratum corneum, but also in viable epidermis and dermis. Caproyl-PL could barely be detected in the receptor fluid after application to either full-thickness or stripped skin. PL, derived from caproyl-PL, was, however, detected in receptor fluid after extensive hydrolysis of caproyl-PL in viable skin. Permeation of PL was markedly decreased under CES inhibition, indicating that the net flux of caproyl-PL is dependent on its conversion rate to PL.
使用前药(一种将活性药物与亲脂性取代基缀合的化合物)是增加药物经皮吸收的有效方法。然而,皮肤中的水解酶活性在人类或实验动物中很少被研究。在本研究中,我们重点研究了大鼠皮肤酯酶的鉴定以及前药在大鼠皮肤透皮过程中的水解。我们发现羧基酯酶(CES),尤其是大鼠 CES1 同工酶,水解酶 A,在大鼠皮肤中表达,并且 p-硝基苯酰衍生物和己酰基普萘洛尔(PL)的水解在皮肤匀浆的 9000g 上清部分中比在肝微粒体中低 20 倍。使用流通扩散池对己酰基-PL 在大鼠全厚皮和去角质皮上的渗透进行了研究。己酰基-PL 很容易分配到角质层并保留,不仅在角质层中,而且在有活力的表皮和真皮中也保留。己酰基-PL 在应用于全厚皮或去角质皮后几乎无法在受体液中检测到。然而,在有活力的皮肤中,己酰基-PL 广泛水解后,可在受体液中检测到 PL。PL 的渗透明显减少,在 CES 抑制下,表明己酰基-PL 的净通量取决于其转化为 PL 的转化率。